However, in both cases, NICE immediately published draft guidance that concluded the anti-amyloid drugs were too expensive to ...

The benefits of Alzheimer’s treatments donanemab and lecanemab remain too small to justify the additional costs ...

Two drugs to treat Alzheimer’s disease have been rejected for use on the NHS because their benefits are “too small” to ...

Explore key strategies for managing dementia confusion and Alzheimer’s. Learn about recognizing signs, using the Confusion Assessment Method, and adapting daily routines for better care of affected in ...

Two breakthrough Alzheimer's drugs have been deemed far too expensive, for too little benefit, to be offered on the NHS.The ...

Galpin said his mother’s general demeanor improved, and as a former cheerleader, she gets particularly excited when local cheerleaders stop by.

Eli Lilly said on Thursday it would appeal against a UK agency's recommendation to not reimburse the cost of Alzheimer's drug ...

Alzheimer's is becoming more and more common across the U.S. According to the Alzheimer's Association, more than 7 million Americans are living with the disease ...

June is brain and Alzheimer’s Disease Awareness Month, a time to focus on our brains’ health. As we age, memory lapses and ...

According to the Alzheimer’s Association, over 7 million Americans are living with Alzheimer’s disease in 2025, and that ...

People with better cognitive health are at lower risk of later Alzheimer's disease, but genetics can interfere with this, ...